Piman Pocasap

Khon Kaen, 40002, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Identification of Prognostic Factors in Esophageal Cancer Using Machine Learning: A Retrospective Study Based on the SEER Database.

Identification of Prognostic Factors in Esophageal Cancer Using Machine Learning: A Retrospective Study Based on the SEER Database.

Journal: Journal of clinical medicine

Published: March 11, 2026

Unveiling the Anticancer Potential and Molecular Mechanisms of Fangchinoline Against Cholangiocarcinoma Using FTIR Microspectroscopy, In Vitro and In Silico Approaches.

Unveiling the Anticancer Potential and Molecular Mechanisms of Fangchinoline Against Cholangiocarcinoma Using FTIR Microspectroscopy, In Vitro and In Silico Approaches.

Journal: Integrative cancer therapies

Published: November 20, 2025

Repurposing Rosiglitazone Induces Apoptosis Accompanied by Impaired Antioxidant Defense in Cholangiocarcinoma Cells: Findings from Proteomic and Functional Analyses.

Repurposing Rosiglitazone Induces Apoptosis Accompanied by Impaired Antioxidant Defense in Cholangiocarcinoma Cells: Findings from Proteomic and Functional Analyses.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 15, 2025

Antihypertensive Effects of Diosmetin in Hypertension-Induced Cardiovascular Abnormalities in Rats.

Antihypertensive Effects of Diosmetin in Hypertension-Induced Cardiovascular Abnormalities in Rats.

Journal: Journal of experimental pharmacology

Published: May 20, 2025

Unveiling the molecular mechanism of diosmin to resolve cardiovascular dysfunction and remodeling in hypertension.

Unveiling the molecular mechanism of diosmin to resolve cardiovascular dysfunction and remodeling in hypertension.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 16, 2025

Synergistic suppression of cholangiocarcinoma cells via DNA damage response and cell cycle arrest by dual targeting PARP and ATM in DNA damage repair pathway.

Synergistic suppression of cholangiocarcinoma cells via DNA damage response and cell cycle arrest by dual targeting PARP and ATM in DNA damage repair pathway.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 25, 2025

Establishment and genomic profiling of cholangiocarcinoma cells with functional characterization.

Establishment and genomic profiling of cholangiocarcinoma cells with functional characterization.

Journal: Scientific reports

Published: August 05, 2024

Pickering Emulsion of Oleoresin from Dipterocarpus alatus Roxb. ex G. Don and Its Antiproliferation in Colon (HCT116) and Liver (HepG2) Cancer Cells.

Pickering Emulsion of Oleoresin from Dipterocarpus alatus Roxb. ex G. Don and Its Antiproliferation in Colon (HCT116) and Liver (HepG2) Cancer Cells.

Journal: Molecules (Basel, Switzerland)

Published: May 11, 2024

Dual blockage of PI3K-mTOR and FGFR induced autophagic cell death in cholangiocarcinoma cells.

Dual blockage of PI3K-mTOR and FGFR induced autophagic cell death in cholangiocarcinoma cells.

Journal: Heliyon

Published: September 25, 2023

Network pharmacology- and cell-based assessments identify the FAK/Src pathway as a molecular target for the antimetastatic effect of momordin Ic against cholangiocarcinoma.

Network pharmacology- and cell-based assessments identify the FAK/Src pathway as a molecular target for the antimetastatic effect of momordin Ic against cholangiocarcinoma.

Journal: Heliyon

Published: September 08, 2023

Thai Rat-Tailed Radish Prevents Hepatocarcinogenesis in Rats by Blocking Mutagenicity, Inducing Hepatic Phase II Enzyme, and Decreasing Hepatic Pro-Inflammatory Cytokine Gene Expression.

Thai Rat-Tailed Radish Prevents Hepatocarcinogenesis in Rats by Blocking Mutagenicity, Inducing Hepatic Phase II Enzyme, and Decreasing Hepatic Pro-Inflammatory Cytokine Gene Expression.

Journal: Cancers

Published: February 07, 2023

Anti-metastatic Potential of Natural Triterpenoid Cucurbitacin B Against Cholangiocarcinoma Cells by Targeting Src Protein.

Anti-metastatic Potential of Natural Triterpenoid Cucurbitacin B Against Cholangiocarcinoma Cells by Targeting Src Protein.

Journal: Integrative cancer therapies

Published: September 26, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026